The Latest in Aggressive Lymphomas

Drug receives breakthrough designation for HL

October 3, 2017

Doc advocates depression screening for cancer patients

October 1, 2017

Maintenance will be a new standard in MCL, doc says

September 29, 2017

Representation in cancer clinical trials

September 27, 2017

Cancer patients want info about marijuana

September 26, 2017

EC expands approval of obinutuzumab in FL

September 23, 2017

Team creates guidelines on CAR T-cell-related toxicity

September 20, 2017

Trials of atezolizumab placed on partial hold

September 19, 2017

FDA approves drug to treat relapsed FL

September 15, 2017

Immune status linked to outcomes of CAR T-cell therapy

September 15, 2017

Report details progress, obstacles in cancer research and care

September 14, 2017

Biosimilar deemed equivalent to reference drug in FL

September 12, 2017

CCSs have higher burden of chronic conditions

September 9, 2017

FDA places full, partial holds on durvalumab trials

September 8, 2017

Nanocarriers could treat leukemia, lymphoma and improve HSCT

September 1, 2017